Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Prevention practices for catheter-associated urinary tract infections lacking in most hospitals

Hospitals are working harder than ever to prevent hospital-acquired infections, but a nationwide survey shows few are aggressively combating the most common one - catheter-associated urinary tract infections.

9 Dec 2011

Breast cancer risks and management updates

A new report that looks at the environmental factors that affect risk of breast cancer is out. It suggests that women can reduce their risk by avoiding unnecessary medical radiation, forgoing hormone treatments for menopause that combine estrogen and progestin, limiting alcohol intake and minimizing weight gain.

8 Dec 2011

Cedars-Sinai neurosurgeon seals off wide-neck aneurysm with new device

As Stephanie Weiss was coming to grips with the news she had two large and three small aneurysms in her brain, the Los Angeles independent travel consultant was told there was no minimally invasive way to treat at least one of the defects: a wide-neck aneurysm. She would have to undergo open-brain surgery.

8 Dec 2011

Study compares two radiation therapy techniques available to women with breast cancer

Accelerated partial breast irradiation (APBI) brachytherapy, the localized form of radiation therapy growing increasingly popular as a treatment choice for women with early-stage breast cancer, is associated with higher rate of later mastectomy, increased radiation-related toxicities and post-operative complications, compared to traditional whole breast irradiation (WBI), according to researchers from The University of Texas MD Anderson Cancer Center.

7 Dec 2011

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORIC-AF European multi-center staged hybrid ablation clinical study.

5 Dec 2011

NASA-developed technology for treatment of hardened arteries in the heart

NASA has signed a patent license agreement that will allow a California company use of NASA-developed technology that could be used to treat hardened arteries in the heart.

3 Dec 2011

USPTO issues Notice of Allowance to Emboline's aortic devices for TAVR procedures

Emboline, Inc., an emerging medical device company, has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its aortic embolic protection devices for percutaneous heart valve repair and replacement.

1 Dec 2011

Toshiba announces new functional-based clinical applications

Toshiba America Medical Systems, Inc. announces new functional-based clinical applications - Dual Energy and Myocardial Perfusion (both works-in-progress), as well as Body Perfusion - for its Aquilion CT systems.

1 Dec 2011

IVC filter study reinforces SIR's guidelines surrounding retrieval or permanent placement

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters-devices used to keep blood clots from traveling to the lungs.

29 Nov 2011

Treatment for acute urinary retention due to BPH varies among countries

Men who experience a sudden inability to pass urine because of a non-cancerous enlarged prostate are hospitalised and treated differently depending on where they live, according to an international study published online by the urology journal BJUI.

28 Nov 2011

Heart operation at the age of 22 hours: Toby’s story

A 22 hours age, baby Toby Dring became Britain’s youngest open heart surgery patient. He had Hypoplastic Left Heart Syndrome and had to be given the life-saving operation when his health deteriorated dramatically at birth. Toby’s condition affects one in 5,000 babies and occurs when the left side of the heart fails to form properly.

28 Nov 2011

IsoRay initiates shipment of GliaSite radiation therapy system

IsoRay, Inc. announced today it has shipped its first GliaSite radiation therapy system. The Company initiated sales after receiving final approval this week from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system.

28 Nov 2011

Ziehm Imaging to highlight Vision RFD hybrid at RSNA 2011

Ziehm Imaging, leading developer, manufacturer and supplier of mobile C-arms, presents its innovative, award-winning product portfolio at RSNA 2011. Latest market analyst reports (GIA[1]) predict substantial growth for the fluoroscopy and mobile C-arm market segments that will be substantially driven by the growing number of minimally invasive procedures.

25 Nov 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Drilling through concrete to create an opening may sound more like construction than medicine, but the approach is similar to what researchers at Orlando Regional Medical Center (ORMC) are doing in a clinical trial to evaluate a device that breaks through hardened coronary arteries, in an effort to prevent heart attacks and relieve chest pain.

23 Nov 2011

IsoRay receives Washington State approval for GliaSite system to treat brain cancer

IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.

22 Nov 2011

FDA allows marketing of Aptus EndoStapling System to treat AAA

The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.

22 Nov 2011

FDA clears Aptus EndoStapling System to treat AAA

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.

21 Nov 2011

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston and Memorial Hermann Heart & Vascular Institute are the first in Houston to implant the artificial heart valve recently approved by the Food and Drug Administration, as well as a newer, smaller version that is part of a clinical trial.

21 Nov 2011

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).

21 Nov 2011

Stem cell therapy for heart failure: two studies two successes

The Center for Disease Control and Prevention says that heart failure affects nearly 6 million Americans leading to considerable risk of death, diminished quality of like and recurrent hospitalizations. Heart failure occurs when the heart can no longer pump enough blood to the rest of the body. The most common cause of heart failure is coronary artery disease, which narrows the small blood vessels that supply blood and oxygen to the heart.

17 Nov 2011

Catheter News and Research

Further Reading

Prevention practices for catheter-associated urinary tract infections lacking in most hospitals

Breast cancer risks and management updates

Cedars-Sinai neurosurgeon seals off wide-neck aneurysm with new device

Study compares two radiation therapy techniques available to women with breast cancer

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

NASA-developed technology for treatment of hardened arteries in the heart

USPTO issues Notice of Allowance to Emboline's aortic devices for TAVR procedures

Toshiba announces new functional-based clinical applications

IVC filter study reinforces SIR's guidelines surrounding retrieval or permanent placement

Treatment for acute urinary retention due to BPH varies among countries

Heart operation at the age of 22 hours: Toby’s story

IsoRay initiates shipment of GliaSite radiation therapy system

Ziehm Imaging to highlight Vision RFD hybrid at RSNA 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

IsoRay receives Washington State approval for GliaSite system to treat brain cancer

FDA allows marketing of Aptus EndoStapling System to treat AAA

FDA clears Aptus EndoStapling System to treat AAA

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Stem cell therapy for heart failure: two studies two successes

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News